03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Rasilez 150mg° : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Khalil Fattal & Fils |
Distributor | Khalil Fattal & Fils |
Laboratory | Novartis |
Responsible Party | Novartis Pharma AG |
Origin | Switzerland |
Manufacturer | Novartis Farma SPA |
Origin | Italy |
ATC | C09XA02 |
Revision Date | 01/07/2010 |
Rasilez 150mg° :
Rasilez 150mg° :
Rasilez 150mg° :
Rasilez 150mg° :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Rasilez 150mg° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Acute hepatic failure | Not known |
Acute kidney injury | Uncommon |
Anaphylactic reactions | Rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Arthralgia (Pain joint) (Joint ache) | Common |
Blood creatinine increased | Rare |
Blood potassium increased | Not known |
Cough | Uncommon |
Diarrhoea (Diarrhea) | Common |
Dizziness | Common |
Dyspnoea (dyspnea) | Not known |
Erythema | Rare |
Haematocrit decreased | Rare |
Haemoglobin decreased | Rare |
Headache | Common |
Hepatic enzyme increased | Uncommon |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatitis | Not known |
Hyperkalaemia | Common |
Hypersensitivity | Rare |
Hyponatraemia (Hyponatremia) | Not known |
Hypotension | Uncommon |
Jaundice | Not known |
Lip swelling | Not known |
Liver disorder | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Uncommon |
Nausea | Not known |
Oedema peripheral | Uncommon |
Oral disorder | Uncommon |
Palpitations | Uncommon |
Pharyngeal oedema | Not known |
Pruritus | Uncommon |
Renal impairment | Uncommon |
Skin rash | Uncommon |
Skin reaction | Uncommon |
Stevens-Johnson syndrome | Uncommon |
Swelling face | Not known |
Swollen tongue | Not known |
Urticaria | Uncommon |
Vertigo | Not known |
Vomiting | Not known |
Rasilez 150mg° :
Different Units By MoH Code
Rasilez 150mg° MoH 7619 :
Form | Tablet, Film-Coated |
Package Size | Box of 28 |
Strength | 150mg |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 222945/14 |
Submission date | 01/01/2014 |
Registration Year | 2014 |
Archived Date | 2017 |
Withdrawn Date | 04/05/2021 |
Price Comparison
● Country: | UK | |
● Package Size: | 28 | |
● Public Price: | 28.51 GBP | ( 3,240,132.99 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,0182 GBP | ( 113,649.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 28 | |
● Public Price: | 44.7 CHF | ( 4,622,874.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,5964 CHF | ( 103,420.00 LBP ) |
● Exfactory Price: | 24.63 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 28 | |
● Public Price: | 37.7 EUR | ( 3,652,225.20 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,3464 EUR | ( 96,876.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 22/06/2017 | |
● Type: | Medicine Non Marketed |
● Country: | The Netherlands | |
● Package Size: | 28 | |
● Public Price: | 29.7 EUR | ( 2,877,217.20 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,0607 EUR | ( 96,876.00 LBP ) |
● Pharmacy Price: | 22.7 EUR | ( 2199085.2 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 28 | |
● Public Price: | 112 AED | ( 2,706,032.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 4 AED | ( 96,644.00 LBP ) |
● Pharmacy Price: | 90.1 AED | ( 2176906.1 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 28's (7's Blister x 4) | |
● Public Price: | 112 AED | ( 2,706,032.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 4 AED | ( 96,644.00 LBP ) |
● Pharmacy Price: | 90.1 AED | ( 2176906.1 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 28 | |
● Public Price: | 98.1 SAR | ( 2,319,084.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 3,5036 SAR | ( 70,920.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
● Country: | Cyprus | |
● Package Size: | 28 TABS | |
● Public Price: | 24.34 EUR | ( 2,357,961.84 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,8693 EUR | ( 0.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Iceland | |
● Package Size: | 98stk | |
● Public Price: | 15.36 ISK | ( 9,907.20 LBP ) |
● Pack size unit used: | 98 | |
● Cost/Unit: | 0,1567 ISK | ( 0.00 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/08/2017 |
● Country: | France | |
● Package Size: | 30 | |
● Public Price: | 17.03 EUR | ( 1,649,798.28 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,5677 EUR | ( 0.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Ireland | |
● Package Size: | 28 | |
● Public Price: | 21.52 EUR | ( 2,084,771.52 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,7686 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 20 EUR | |
● Pricing Date: | 09/10/2020 | |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File